Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea
抑制肠道顶端 cAMP/cGMP 转运蛋白 (MRP4) 诱发腹泻
基本信息
- 批准号:8622190
- 负责人:
- 金额:$ 34.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal PainAddressAffectApicalApplications GrantsAttentionAttenuatedCell membraneCellsChloride ChannelsChloride IonChloridesChronic DiseaseColitisColonCoupledCouplesCouplingCrohn&aposs diseaseCyclic AMPCyclic GMPCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaDiseaseDistal part of ileumEpithelialEpithelial CellsEuropeFluids and SecretionsFundingGastrointestinal tract structureGenerationsGoalsHealthcareHigh PrevalenceHumanIn VitroIndividualInflammationInflammatory Bowel DiseasesKnockout MiceMacromolecular ComplexesMethodsModelingMucous MembraneNitric OxideNorth AmericaP-GlycoproteinsPDZ proteinPathway interactionsPharmaceutical PreparationsPhenotypePredispositionProcessProductionProteinsReportingResearchResourcesScaffolding ProteinSignal TransductionSodium Dextran SulfateSusceptibility GeneSymptomsTestingTherapeutic InterventionTissuesUlcerative ColitisUnited Statesapical membraneclinically relevantdisease phenotypegastrointestinal epitheliumhuman NOS2A proteinmolecular assembly/self assemblynoveloverexpressionprotein protein interactionpublic health relevancesodium-hydrogen exchanger regulatory factor
项目摘要
DESCRIPTION (provided by applicant): This application for continued support will focus on studying how protein-protein interactions among the cystic fibrosis transmembrane conductance regulator (CFTR), multidrug resistance protein 4 (MRP4) and inducible nitric oxide synthase (iNOS) contribute to the diarrheal symptom observed in Ulcerative Colitis (UC). Our unifying hypothesis is that CFTR, NHERF2, MRP4 and iNOS form a macromolecular complex at or near the plasma membrane in gut epithelial in UC and this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. Specifically, we proposed that iNOS is overexpressed at the plasma membrane of gut epithelia in UC, resulting in the production of sustained high level of nitric oxide (NO) which triggers NO-cGMP pathway and generates compartmentalized cGMP. Since iNOS forms a macromolecular complex with CFTR, NHERF2 and MRP4 at or near the plasma membrane, this NO-dependent compartmentalized cGMP triggers the hyperactivation of CFTR chloride channels and thus causes diarrhea phenotype. Disruption of the macromolecular complex will abolish the functional coupling of iNOS-dependent cGMP generation and CFTR Cl- channel function. The specific aims of this proposal are: Specific Aim 1. To test the hypothesis that iNOS is overexpressed in UC-affected human gut epithelia and to test whether it is coupled to CFTR and MRP4 and upregulates CFTR Cl- channel function Specific Aim 2. To test the hypothesis that iNOS, CFTR, and MRP4 form a macromolecular complex at or near the plasma membrane of gut epithelial cells and that this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. The proposed studies will not only help us better understand the mechanisms underlying the diarrhea symptom commonly observed in UC, but probably provide novel targets and methods for therapeutic interventions of the disease. Therefore, the studies proposed in this application will have clinical relevance for many individuals suffering from UC and also for those suffering from certain forms of secretory diarrheas.
描述(申请人提供):这份持续支持的申请将专注于研究囊性纤维化跨膜传导调节因子(CFTR)、多药耐药蛋白4(MRP4)和诱导型一氧化氮合酶(INOS)之间的蛋白质-蛋白质相互作用如何导致溃疡性结肠炎(UC)的腹泻症状。我们的统一假设是,CFTR、NHERF2、MRP4和iNOS在UC的肠上皮细胞膜或质膜附近形成一个大分子复合体,这个大分子复合体是UC腹泻发病过程所必需的。具体地说,我们认为在UC中iNOS在肠上皮细胞的质膜上过度表达,导致持续高水平的一氧化氮(NO)的产生,从而触发NO-cGMP途径并产生区域化的cGMP。由于iNOS在质膜上或质膜附近与CFTR、NHERF2和MRP4形成大分子复合体,这种NO依赖的区段化cGMP触发CFTR氯通道的过度激活,从而导致腹泻表型。大分子复合体的破坏将取消iNOS依赖的cGMP生成和CFTRCl-通道功能的功能耦合。本研究的具体目的是:1.验证iNOS在UC患者的肠上皮细胞中高表达的假设,并验证其是否与CFTR和MRP4偶联并上调CFTRCl-通道功能;2.验证iNOS、CFTR和MRP4在肠上皮细胞质膜上或质膜附近形成大分子复合体的假设,以及该大分子复合体是UC腹泻发病过程所必需的。这些研究不仅有助于我们更好地了解UC常见腹泻症状的机制,而且可能为该病的治疗干预提供新的靶点和方法。因此,本申请中建议的研究将对许多UC患者和某些形式的分泌性腹泻患者具有临床意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anjaparavanda P Naren其他文献
Anjaparavanda P Naren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anjaparavanda P Naren', 18)}}的其他基金
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10406127 - 财政年份:2020
- 资助金额:
$ 34.66万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10454293 - 财政年份:2020
- 资助金额:
$ 34.66万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10656430 - 财政年份:2020
- 资助金额:
$ 34.66万 - 项目类别:
Personalized Cystic Fibrosis Therapy and Research Center
个性化囊性纤维化治疗和研究中心
- 批准号:
10672704 - 财政年份:2018
- 资助金额:
$ 34.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.66万 - 项目类别:
Research Grant